Penumbra, Inc. (NYSE:PEN - Get Free Report) EVP Johanna Roberts sold 600 shares of the company's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $239.74, for a total value of $143,844.00. Following the sale, the executive vice president now owns 64,044 shares in the company, valued at approximately $15,353,908.56. This represents a 0.93 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Johanna Roberts also recently made the following trade(s):
- On Tuesday, October 1st, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $190.76, for a total value of $114,456.00.
- On Tuesday, September 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $206.22, for a total value of $123,732.00.
Penumbra Price Performance
Shares of Penumbra stock opened at $237.04 on Wednesday. The business has a 50 day moving average of $208.19 and a 200 day moving average of $196.22. Penumbra, Inc. has a 52 week low of $148.00 and a 52 week high of $277.34. The company has a market cap of $9.10 billion, a PE ratio of 275.63, a P/E/G ratio of 2.41 and a beta of 0.51. The company has a quick ratio of 3.25, a current ratio of 5.82 and a debt-to-equity ratio of 0.02.
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
From Darwin | Ad
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!
Penumbra (NYSE:PEN - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.69 by $0.16. The business had revenue of $301.04 million during the quarter, compared to analyst estimates of $297.36 million. Penumbra had a net margin of 2.97% and a return on equity of 8.99%. The company's revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.67 EPS. As a group, equities research analysts forecast that Penumbra, Inc. will post 2.79 earnings per share for the current year.
Penumbra declared that its board has authorized a share repurchase program on Tuesday, August 13th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to buy up to 2.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its shares are undervalued.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. FMR LLC grew its stake in Penumbra by 2.1% in the third quarter. FMR LLC now owns 5,896,396 shares of the company's stock worth $1,145,729,000 after purchasing an additional 121,465 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Penumbra by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,690,660 shares of the company's stock valued at $823,681,000 after buying an additional 32,557 shares in the last quarter. Champlain Investment Partners LLC boosted its holdings in shares of Penumbra by 20.6% during the 3rd quarter. Champlain Investment Partners LLC now owns 1,547,972 shares of the company's stock valued at $300,786,000 after buying an additional 264,122 shares in the last quarter. State Street Corp grew its position in shares of Penumbra by 0.3% in the 3rd quarter. State Street Corp now owns 1,236,671 shares of the company's stock worth $240,298,000 after buying an additional 3,863 shares during the period. Finally, RTW Investments LP increased its stake in shares of Penumbra by 7.2% in the 3rd quarter. RTW Investments LP now owns 795,750 shares of the company's stock worth $154,622,000 after acquiring an additional 53,645 shares in the last quarter. Institutional investors own 88.88% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the stock. Needham & Company LLC restated a "hold" rating on shares of Penumbra in a research report on Thursday, October 31st. Piper Sandler lifted their price target on Penumbra from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. Citigroup increased their price objective on Penumbra from $178.00 to $200.00 and gave the company a "neutral" rating in a research report on Thursday, August 22nd. BTIG Research boosted their target price on Penumbra from $224.00 to $234.00 and gave the stock a "buy" rating in a research report on Monday, October 14th. Finally, Truist Financial increased their price target on shares of Penumbra from $200.00 to $235.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Five equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $226.67.
Check Out Our Latest Research Report on PEN
About Penumbra
(
Get Free Report)
Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
